Kanada - Kiingereza - Health Canada

novartis pharmaceuticals canada inc - flumethasone pivalate - cream - .03% - flumethasone pivalate .03% - anti-inflammatory agents

Kanada - Kiingereza - Health Canada

novartis pharmaceuticals canada inc - flumethasone pivalate; clioquinol - ointment - .02%; 3% - flumethasone pivalate .02%; clioquinol 3% - miscellaneous antifungals

Kanada - Kiingereza - Health Canada

paladin labs inc. - flumethasone pivalate; clioquinol - drops - 0.02%; 1% - flumethasone pivalate 0.02%; clioquinol 1% - antibacterials

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - imidacloprid; flumethrin - collar, medalion - imidacloprid guanidine active 100.0 mg/g; flumethrin pyrethroid active 45.0 mg/g - parasiticides

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - imidacloprid; flumethrin - collar, medalion - imidacloprid guanidine active 100.0 mg/g; flumethrin pyrethroid active 45.0 mg/g - parasiticides

Australia - Kiingereza - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - imidacloprid; flumethrin - collar, medalion - imidacloprid guanidine active 100.0 mg/g; flumethrin pyrethroid active 45.0 mg/g - parasiticides

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - flumetasone pivalate, quantity: 0.2 mg/ml; clioquinol, quantity: 10 mg/ml - ear drops - excipient ingredients: macrogol 300 - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. new indications were approved as specified in the letter of 29 june 1992 from dr alex proudfoot. indicated for the treatment of eczema of the external auditory meatus in which secondary infection with micro-organisms sensitive to clioquinol has occurred. otitis externa. otomycosis.

Marekani - Kiingereza - NLM (National Library of Medicine)

bimeda, inc. - flumethasone (unii: lr3cd8sx89) (flumethasone - unii:lr3cd8sx89) - indications bimasone is recommended for the various rheumatic, allergic, dermatologic and other disease states which are known to be responsive to the anti-inflammatory corticoids. equine indications 1.  musculoskeletal conditions due to inflammation, where permanent structural changes do not exist, such as bursitis, carpitis, osselets and myositis. following therapy an appropriate period of rest should be instituted to allow a more normal return to function of the affected part. 2.  in allergic states such as hives, urticaria and insect bites. canine indications 1.  musculoskeletal conditions due to inflammation of muscles or joints and accessory structures, where permanent structural changes do not exist, such as arthritis, osteoarthritis, the disc syndrome and myositis. in septic arthritis appropriate antibacterial therapy should be concurrently administered. 2.  in certain acute and chronic dermatoses of varying etiology to help control the pruritus, irritation and inflammation associated with these conditions. the drug has proven useful in otitis externa in conjunction with topical medication for similar reasons. 3.  in allergic states such as hives, urticaria and insect bites. 4.  shock and shock-like states, (4) by intravenous administration. feline indications 1.  in certain acute and chronic dermatoses of varying etiology to help control the pruritus, irritation and inflammation associated with these conditions. contraindications do not use in viral infections. except for emergency therapy, do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome and peptic ulcers. existence of congestive heart failure, diabetes and osteoporosis are relative contraindications.

Malesia - Kiingereza - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn. bhd. - flumequine -

Malta - Kiingereza - Medicines Authority

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - flumetasone pivalate, clioquinol - ear drops, solution - flumetasone pivalate clioquinol - otologicals